✦ LIBER ✦

Prolonging antiandrogen therapy appears to improve survival duration in patients with stage D2 prostate cancer

Book ID: 120869947
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012330-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relapse on endocrine treatment in patien

Relapse on endocrine treatment in patients with stage d2 prostate cancer: Does second-line hormonal therapy affect survival?

✍ Haim Matzkin; M.Christina Rangel; Mark S. Soloway 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 547 KB

Gleason score and pretreatment prostate-

Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer

✍ William D. Figg; Michael E. Franks; David Venzon; Paul Duray; Michael C. Cox; W. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 230 KB

Androgen suppression therapy, in combina

Androgen suppression therapy, in combination with radiotherapy prolongs overall survival in men with clinically localised prostate cancer: Abstracted from: D’Amico AV, Manola J, Loffredo M et al. 6-month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancer. A randomized controlled trial. JAMA 2004;292:821–27.

✍ Juanita Crook 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 90 KB

PCD11: COST-EFFECTIVENESS OF THE THERAPY

PCD11: COST-EFFECTIVENESS OF THE THERAPY WITH IODINE 125-SEED IMPLANTATION IN PATIENTS WITH STAGE T1 AND T2 PROSTATE CARCINOMA IN COMPARISON TO TOTAL PROSTATECTOMY AND BEAM RADIATION IN 3D-TECHNIQUE

✍ J Thomas; B Kremer; Y Bruchhausen; R Rychlik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views